LU82945A1 - Roentgenamorphe,physiologisch vertraegliche saeureadditions-salze von ergot-bzw.dihydroergot-alkaloiden,verfahren zu deren herstellung sowie ihre verwendung in der therapie - Google Patents

Roentgenamorphe,physiologisch vertraegliche saeureadditions-salze von ergot-bzw.dihydroergot-alkaloiden,verfahren zu deren herstellung sowie ihre verwendung in der therapie Download PDF

Info

Publication number
LU82945A1
LU82945A1 LU82945A LU82945A LU82945A1 LU 82945 A1 LU82945 A1 LU 82945A1 LU 82945 A LU82945 A LU 82945A LU 82945 A LU82945 A LU 82945A LU 82945 A1 LU82945 A1 LU 82945A1
Authority
LU
Luxembourg
Prior art keywords
acid addition
addition salts
ray amorphous
alkaloids
ergot
Prior art date
Application number
LU82945A
Other languages
German (de)
English (en)
Inventor
M Mohar
R Rucman
Original Assignee
Lek Tovarna Farmacevtskih
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Tovarna Farmacevtskih filed Critical Lek Tovarna Farmacevtskih
Publication of LU82945A1 publication Critical patent/LU82945A1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
LU82945A 1979-11-22 1980-11-19 Roentgenamorphe,physiologisch vertraegliche saeureadditions-salze von ergot-bzw.dihydroergot-alkaloiden,verfahren zu deren herstellung sowie ihre verwendung in der therapie LU82945A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
YU2867/79A YU41681B (en) 1979-11-22 1979-11-22 Process for preparing x-ray amorhous physiologically tolerated acid additional salts of ergot alcaloids and dihydroergot alcaloids
YU286779 1979-11-22

Publications (1)

Publication Number Publication Date
LU82945A1 true LU82945A1 (de) 1981-03-26

Family

ID=25558910

Family Applications (1)

Application Number Title Priority Date Filing Date
LU82945A LU82945A1 (de) 1979-11-22 1980-11-19 Roentgenamorphe,physiologisch vertraegliche saeureadditions-salze von ergot-bzw.dihydroergot-alkaloiden,verfahren zu deren herstellung sowie ihre verwendung in der therapie

Country Status (10)

Country Link
JP (1) JPS56164195A (es)
BE (1) BE886262A (es)
DE (1) DE3043832A1 (es)
ES (1) ES496969A0 (es)
FR (1) FR2470133A1 (es)
GB (1) GB2063864B (es)
LU (1) LU82945A1 (es)
NL (1) NL8006341A (es)
PT (1) PT72078B (es)
YU (1) YU41681B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2629744A1 (fr) * 1988-04-06 1989-10-13 Wurth Paul Sa Machine de percage de trous de coulee d'un four a cuve

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2629744A1 (fr) * 1988-04-06 1989-10-13 Wurth Paul Sa Machine de percage de trous de coulee d'un four a cuve

Also Published As

Publication number Publication date
NL8006341A (nl) 1981-06-16
YU286779A (en) 1983-06-30
GB2063864A (en) 1981-06-10
PT72078B (en) 1981-09-29
FR2470133A1 (fr) 1981-05-29
ES8205796A1 (es) 1982-08-01
FR2470133B3 (es) 1982-09-03
ES496969A0 (es) 1982-08-01
DE3043832A1 (de) 1981-09-17
JPS56164195A (en) 1981-12-17
YU41681B (en) 1987-12-31
GB2063864B (en) 1983-07-20
PT72078A (en) 1980-12-01
BE886262A (fr) 1981-03-16

Similar Documents

Publication Publication Date Title
DE60108154T2 (de) Pharmazeutische Zubereitungen enthaltend Clavulansäure
DE69625696T2 (de) Verwendung eines thienotriazoldiazepins zur erhöhung des apolopoproteins a-i niveaus
DE69500652T2 (de) Nefazodon-Salze mit verbesserter Auflösungsgeschwindigkeit
DE69218557T2 (de) Stabile Zusammensetzung die ein Enalapril-Salz enthält, Verfahren zu ihrer Herstellung und ihre Verwendung
DE3222250C2 (es)
DE1817843A1 (de) Arzneimittel zur Relaxion glatter Muskeln
DE29924789U1 (de) Neue Kristallmodifikation N von Torasemid
DE19602964A1 (de) Neue Morphinderivate, Verfahren zu deren Herstellung und deren Verwendung
DE3212736A1 (de) Verwendung von dihydropyridinen in arzneimitteln mit salidiuretischer wirkung
DE60124717T2 (de) Aryl-sulfonamide als serotonin-antagonisten für die behandlung von fettleibigkeit
CH647677A5 (de) 4'-(acridinylamino)-methansulfon-anisidid enthaltende pharmazeutische zusammensetzung.
DE69306990T2 (de) Physostigmin-Derivate, ihre Verwendung und sie enthaltende pharmazeutische Formulierungen
LU82945A1 (de) Roentgenamorphe,physiologisch vertraegliche saeureadditions-salze von ergot-bzw.dihydroergot-alkaloiden,verfahren zu deren herstellung sowie ihre verwendung in der therapie
DE69609314T2 (de) Amorph piretanide, polymorphe davon, verfahren zur dessen herstellung und ihre verwendung
EP0132595B1 (de) Tokolytisches Mittel
DE2935776C2 (es)
DE68912740T2 (de) Azazyklische Derivate mit harntreibender Wirkung.
DE1620177C3 (de) N-(2-Hydroxyäthyl)-piperazinocarboxymethyl-tetracyclin, dessen pharmakologisch verwendbaren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DD158397A5 (de) Verfahren zur herstellung von isophthalsaeurepicolylamidmonohydrat
DE2636328A1 (de) Arzneimittel
EP0253293B1 (de) Neue Guanidiniumasparaginate
EP0192098B1 (de) Verwendung des 2-Amino-6-allyl-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepins zur Herstellung eines zur Behandlung der Parkinsonschen Erkrankung bzw. des Parkinsonismus geeigneten Arzneimittels
DE2707763A1 (de) Verwendung von vincamin zur behandlung von kreislauferkrankungen des gehirns und dazu geeignetes arzneimittel
EP0429856B1 (de) Neue Arzneizubereitungen, ein Metallsalz des Ibuprofens enthaltend und Verfahren zur Herstellung derselben
DE2131616A1 (de) Pharmazeutisches Praeparat